Free online reference management for clinicians and scientists

Sign up now

Recent "heart disease" articles

  • These articles and links have been posted by Connotea users using the tag "heart disease".
  • To add to this collection, or to start your own library:

Learn more

Watch a short video (2m 41s)

EXPORT LIST RSS ?
Bookmarks matching tag "heart disease"
 
Number of articles per page:
10 | 25 | 50 | 100
 
Study Refutes Protein's Role in Heart Attacks - on article in JAMA
sciencenow.sciencemag.org
A new study may be the last word in a controversy that's plagued cardiovascular disease research for years: whether a marker of inflammation known as C-reactive protein (CRP) drives heart attacks and strokes. In a survey of more than 128,000 people, researchers have found that genes that raise CRP levels don't make cardiovascular disease more likely. Although the study arrives at the same conclusion as earlier work, its massive size makes it statistically the most powerful test yet of this question and tough to refute, say experts. Produced by the liver, CRP has long been eyed as a suspect in heart disease. In part, that's because of observational studies, which regularly find that higher CRP levels are associated with later heart trouble. CRP is also a vague indicator of many health problems that hike the risk of heart attacks and strokes, including obesity and type 2 diabetes. But these kinds of associations don't mean that CRP is actually causing heart attacks. Indeed, last fall, Danish researchers reported that genes that raise CRP don't appear to cause cardiovascular disease (ScienceNOW, 29 October 2008). Now, a team of three dozen researchers from the United Kingdom, Canada, Germany, and elsewhere have teamed up to examine the question again. They drew on numerous health studies, which have banked DNA from tens of thousands of participants. Like the earlier Danish group, this one, led by epidemiologist Paul Elliott of Imperial College London, began with a simple premise: If high CRP levels cause heart attacks, then genes that raise CRP levels should also raise the risk of heart attacks. The researchers studied three variants that each raised CRP by about 20%. Then they tested whether having at least one of these variants made cardiovascular disease more likely in more than 28,000 people with disease and in 100,000 people without. The result: The genes had no effect on heart disease.
 
Fatal CVD Risk Increases with Inflammation - in Cardiovascular, Coronary Artery Disease from MedPage Today
www.medpagetoday.com
Posted by abipaul7 to heart disease on Tue Jun 23 2009 at 17:00 UTC | info | related
 
Statins May Play a Role in Myocardial Hemodynamics - in Meeting Coverage, ASE from MedPage Today
www.medpagetoday.com
Posted by abipaul7 to heart disease statins on Tue Jun 09 2009 at 20:55 UTC | info | related
 
For Heart Disease in Diabetes, Medication Matches Revascularization - in Meeting Coverage, ADA from MedPage Today
www.medpagetoday.com
Posted by abipaul7 to heart disease diabetes on Tue Jun 09 2009 at 01:20 UTC | info | related
 
Quality Heart Health Supplements
www.heartvitamins.org
Quality heart supplements for maintenance of healthy blood pressure and cholesterol, and treatment of existing heart disease.
 
No Clear Value for Aspirin in Primary Cardioprevention - in Cardiovascular, Prevention from MedPage Today
www.medpagetoday.com
Posted by abipaul7 to aspirin heart disease on Fri May 29 2009 at 18:12 UTC | info | related
 
Give Blood Pressure Drugs to All
www.medscape.com
 
Obesity Paradox Probed in New Review
www.medscape.com
 
Further Evidence Supports Vitamin-D-Deficiency Link to CHD
cme.medscape.com
 
The sepsis seesaw: seeking a heart salve
Peter Ward
Nat Med 15 (5), 497-8 (May 2009)
Sepsis in humans frequently follows the body's attempt to thwart infectious agents such as bacteria, viruses and fungi. In many respects, the development of sepsis represents the harmful consequences of exuberant innate immune responses, resulting in high levels of proinflammatory mediators that are associated with organ failure, primarily in the heart, lungs, liver and kidneys. The early phases of sepsis are often associated with the onset of immunosuppression, which may compromise the body's ability to cope with infectious agents1. After the onset of sepsis, patients often develop 'septic shock', which is associated with a decrease in blood pressure, requiring the administration of vasopressors to maintain adequate blood pressure for organ perfusion. Such support may restore blood pressure, but does not address the cause, and it sometimes fails to adequately improve vascular perfusion of vital organs, including the brain. Very little is understood about the cause of falling cardiac output in septic shock, although cardiac failure of this type, referred to as septic cardiomyopathy, is considered to be reversible and does not seem to involve structural damage of the heart2. Several recent studies have provided insights into how the contractile power of the heart wanes during septic shock2. These studies have identified cardiosuppressive factors that are induced during sepsis and impair contractility of cardiomyocytes, the contractile cells of the heart. At least three types of factors adversely affect cardiomyocytes: bacterial lipopolysaccharide (LPS), the complement activation product C5a and certain cytokines (interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha) and IL-6). Blockade of these factors or their signaling pathways may be a promising therapeutic approach to treat complications of sepsis.

<< Prev 0      Showing entries 1 to 10 of 127 total      Next 10 >>